Validation of a serum microRNA panel as biomarkers for early diagnosis of hepatocellular carcinoma post-hepatitis C infection in Egyptian patients

doi:10.3748/wjg.v23.i21.3864

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 23, Issue 21

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9739)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-5) series.

Item

Count

PDF

609

WORD

455

HTML

5241

Figures (1-5)

292

Tables (1-5)

260

Sum=6857

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1182

Download

1076

Sum=2258

Jun 7, 2017 (publication date) through Jan 2, 2025

Times Cited of This Article

Times Cited (39)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Control Study

World J Gastroenterol. Jun 7, 2017; 23(21): 3864-3875
Published online Jun 7, 2017. doi: 10.3748/wjg.v23.i21.3864

Open in New Tab Full Size Figure Download Figure

Figure 1 Differential serum miRNA expression levels in non-infected healthy controls compared to hepatocellular carcinoma patients.

Open in New Tab Full Size Figure Download Figure

Figure 2 Efficacy of studied miRNAs in hepatocellular carcinoma non-malignant differentiation using receiver operating characteristics curve analysis. Hepatocellular carcinoma (HCC) (n = 224) and healthy control (n = 84).

Open in New Tab Full Size Figure Download Figure

Figure 3 Efficacy of studied miRNAs in hepatocellular carcinoma, hepatitis C virus categorization using receiver operating characteristics curve analysis. Hepatocellular carcinoma (n = 224) and hepatitis C virus (n = 250). AUC: Area under the curve.

Open in New Tab Full Size Figure Download Figure

Figure 4 Diagnostic activity of the panel of miRNAs studied.

Open in New Tab Full Size Figure Download Figure

Figure 5 Comparison between miRNA panel and alpha-fetoprotein using receiver operating characteristic curve. AFP: Alpha-fetoprotein; HCC: Hepatocellular carcinoma.

Citation: Elemeery MN, Badr AN, Mohamed MA, Ghareeb DA. Validation of a serum microRNA panel as biomarkers for early diagnosis of hepatocellular carcinoma post-hepatitis C infection in Egyptian patients. World J Gastroenterol 2017; 23(21): 3864-3875
URL: https://www.wjgnet.com/1007-9327/full/v23/i21/3864.htm
DOI: https://dx.doi.org/10.3748/wjg.v23.i21.3864